Latest news
- Beating Blood Cancers Blog
- Our publications
- Dedicated to beating blood cancers
- Disease newsletter archive
- Lifeblood
- Myeloma News
- Myeloma News: March 2020
- Viruses & blood cancer – what you need to know
- Leukaemia Foundation invests $2.6m+ in innovative myeloma research
- PBAC reconsidered plitidepsin for myeloma
- The tale of ‘the terrible twosome’ #kickingmyelomasbutt
- Caring for the Carer
- Australians are swabbing a cheek to save a life
- What’s CAR T-cell therapy?
- Myeloma News: March 2020
- Willing to help
- Lymphoma News
- Lymphoma News: April 2020
- Lymphoma News: October 2019
- ‘First of its kind’ blood cancer report proposes new optimal care pathway for people with lymphoma
- ABMDR recruitment campaign – 5,000 new stem cell donors by September 2020
- Bronwyn advocated for when and where she was treated
- Shine a light on blood cancer at Light the Night
- WhiMSICAL study – on the way to 1000 participants and ‘big data’
- Lymphoma News: August 2019
- Lymphoma News: June 2019
- MDS News
- MDS News: April 2020
- MDS News: October 2019
- ‘First of its kind’ blood cancer report includes opportunities for improved treatment for MDS
- ABMDR recruitment campaign – 5,000 new stem cell donors by 2020
- Merrick from Berwick has “reported for duty” since 2012
- Quest to better understand MDS and find out more effective therapies
- Shine a light on blood cancer at Light the Night
- MDS News: August 2019
- CLL News
- CLL News: May 2020
- CLL News: November 2019
- CLL News: September 2019
- Cancer Concierge Pilot: Assessing CLL needs and providing targeted interventions
- Chemo-free drug – Venetoclax – now listed on the PBS for CLL
- Going through treatment has taken the worry out of watch and wait for Patricia
- Information, insights, even exercise covered at the CLL patient forum
- September spotlights blood cancer and our bold new goal
- MPN News
- MPN News: February 2020
- Ken isn’t ruled by his MPN and is optimistic about his future
- New classifications of MPN mean better diagnostics and more definitive prognoses
- ABMDR recruitment campaign – 5,000 new stem cell donors by September 2020
- Caring for the Carer
- Moving towards achieving the vision of Zero Lives Lost to Blood Cancer by 2035
- MPN News: February 2020
- CML News
- Moving towards achieving the vision of Zero Lives Lost to Blood Cancer by 2035
- Q&A: Professor Timothy Hughes – Part 1
- Q&A: Professor Timothy Hughes – Part 2
- Rick’s “very happy” with his decision to change to generic imatinib
- Asciminib – the biggest breakthrough yet in CML treatment
- Caring for the Carer
- A bone marrow transplant saved Judi’s life after a shock diagnosis
- ALL News
- ALL News: March 2020
- Viruses & blood cancer – what you need to know
- Brett’s well and back living in the moment
- Leukaemia Foundation invests $3.9m+ in innovative ALL research
- PBS listing of blinatumomab extended
- Understanding immune system behaviour in blood cancers
- Australians are swabbing a cheek to save a life
- Caring for the Carer
- What’s CAR T-cell therapy?
- ALL News: March 2020
- AML News
- Amyloidosis News
- Living Well News
- Living Well News: Issue 1 / 2019
- Cancer-related fatigue – what it is, how it can affect you and how to manage it
- Cherryl meditates to reduce stress and for her healing
- Cooking for chemo recipes: comfort food for winter
- Talking humanity in healthcare with David Joske
- Tereena goes to her “happy place” when she’s in pain or discomfort
- The mind/body connection in healing
- Living Well News: Issue 2 / 2019
- Living Well News: Issue 1 / 2019
- Subscribe
- Latest news
- Social media
- Media contacts
Federal Health Minister Greg Hunt commits to Blood Cancer Taskforce and Action Plan
Wednesday, 17 April 2019
The Leukaemia Foundation welcomes the commitment from the Federal Health Minister Greg Hunt to establish a Blood Cancer Taskforce and Action Plan.
The Blood Cancer Taskforce will work with leading clinicians, researchers and patient groups in the blood cancer community to
Leukaemia Foundation supports Labor’s $20 million blood cancer Right to Trial
Wednesday, 17 April 2019
The Leukaemia Foundation welcomes Federal Labor’s commitment of $20 million to give Australian blood cancer patients faster access to leading clinical trial drugs and therapies through a new Right to Trial program.
Leukaemia Foundation CEO Bill Petch today joined Opposition Leader Bill Shorten and Shadow Health Minister for Health and Medicare Catherine King at
South Australian researchers to develop cutting edge genetic testing
Tuesday, 16 April 2019
The Leukaemia Foundation is funding a cutting-edge diagnostic test that would help clinicians identify specific gene mutations to offer more effective, targeted treatments for Australians living with blood cancer.
The SA Genomics Haematology Malignancies Node will have the first of three tests available across Australia in six
CAR-T therapy receives Federal Government funding allowing young people with ALL to receive innovative treatment
Monday, 15 April 2019,
The Leukaemia Foundation has welcomed today’s announcement by Federal Health Minister Greg Hunt to list CAR-T therapy on the Medicare Benefits Schedule (MBS). The treatment will be for use in paediatric and young adult patients up to 25 years of age with B-cell precursor acute lymphoblastic leukaemia (ALL) that is refractory, in relapse post-transplant,
Welcome commitment to reduce out-of-pocket cancer costs
Friday, 05 April 2019
The Leukaemia Foundation welcomes Federal Labor’s commitment to reducing out-of-pocket costs for cancer patients as part of a $2.3 billion funding package announced in last night’s Federal Budget reply.
The announcement includes funding to remove out-of-pocket costs associated with diagnostic imaging, bulk-billed Medicare items for oncologists and specialist surgeons,
New PBS listing vital to Australians living with B-cell Acute Lymphoblastic Leukaemia
Thursday, 4 April 2019
The Leukaemia Foundation has welcomed news Australians living with B-cell acute lymphoblastic leukaemia (B-ALL) will have access to the drug inotuzumab ozogamicin (Besponsa®) through the Pharmaceutical Benefits Scheme (PBS) after the listing was announced in this week’s Federal Budget.
According to the Federal Government, Australians living with
New Australian facilities announced for break-through CAR-T therapy and other immunotherapy clinical trials
Tuesday, 26 March 2019
The Leukaemia Foundation welcomes the federal government $80 million investment to establish the Peter MacCallum Centre as a new base for Car-T Cell therapy and other immunotherapy clinical trials in Australia.
The funding package would help to build 2,600 square met facilities to manufacture commercial CAR-T
Leukaemia Foundation to partner with Tour de Cure for the inaugural Life Ride
Tuesday, 26 March 2019
The Leukaemia Foundation and Tour de Cure will combine forces in 2019 to host the first Life Ride – an inspiring three-day cycling event to help fund research and find a cure for blood cancer.
The inaugural Life Ride will be held in the spectacular Margaret River region of Western Australia from Sunday,
Treatment for cutaneous T-cell lymphomas to be subsidised through broadened PBS listing
Thursday, 21 March 2019
The Leukaemia Foundation welcomes the Federal Government’s announcement that the Pharmaceutical Benefits Scheme (PBS) listing of brentuximab vedotin (Adcetris®) will be broadened to include treatment of cutaneous T-cell lymphomas (CTCL) from 1 April 2019.
CTCL is a type of non-Hodgkin lymphoma that directly attacks the body’s T-cells, a type of white
Leukaemia Foundation supports Australian women #BalanceForBetter
Thursday, 07 March 2019
The Leukaemia Foundation is proud to support International Women’s Day, a day to acknowledge and celebrate the social, economic, cultural and political achievements of all women across the globe.
This year, the Leukaemia Foundation is thrilled to recognise two innovative Australian Clinical and Science PhD female investigators, whose work is at the forefront of next generation medical